← Leaderboards
Philip Raymond Williams
Boston Children'S Hospital
$2,762,442
Attributed
$3,977,885
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,977,885 · 3
By mechanism
R01$3,977,885 · 3
Top collaborators
- Shiming Chen2 shared
- Zhigang He2 shared
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Zhigang He$31,904,301
- Timothy Tun Hla$35,188,963
- Jonathan Oren Lipton$4,354,722
- Jose Manuel Ordovas-Montanes$2,723,428
- Feng Tian$782,151
Others in their field
Other Rising Stars on “Image”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Gary Mays · Axle Informatics, Llc$58,129,860
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Samuel W Teitelbaum · Arizona State University$13,377,213
- Christopher J. Lindsell · Vanderbilt University Medical Center$10,257,682
- Daofeng Li · Salk Institute For Biological Studies$9,887,266
Research focus
ImagePathway InteractionsPreventCell DeathResponseCell SurvivalIn VivoPreservationRetinal Ganglion CellsExperimental StudyOptic NerveIn Vivo ImagingCessation Of LifeNerve CrushGenesBlindnessMetabolismNerve DegenerationAxon InjuryMetabolicGlaucomaCell TypeAxonImaging Approach
Grant awards (8)
Kinase regulators of retinal ganglion cell survival and axon regeneration$628,760
R01 · FY2025 · EY
Vulnerable and Resilient Cells in Retinal Degeneration$575,017
R01 · FY2025 · EY
Identifying and leveraging strategies of inherently resilient retinal neurons to treat degeneration$385,227
R01 · FY2025 · EY · contact PI
Kinase regulators of retinal ganglion cell survival and axon regeneration$652,092
R01 · FY2024 · EY
Vulnerable and Resilient Cells in Retinal Degeneration$575,017
R01 · FY2024 · EY
Identifying and leveraging strategies of inherently resilient retinal neurons to treat degeneration$385,227
R01 · FY2024 · EY · contact PI
Identifying and leveraging strategies of inherently resilient retinal neurons to treat degeneration$386,445
R01 · FY2023 · EY · contact PI
Identifying and leveraging strategies of inherently resilient retinal neurons to treat degeneration$390,100
R01 · FY2022 · EY · contact PI